Literature DB >> 21076277

Editorial neuroAIDS review.

Paul Shapshak, Pandjassarame Kangueane, Robert K Fujimura, Deborah Commins, Francesco Chiappelli, Elyse Singer, Andrew J Levine, Alireza Minagar, Francis J Novembre, Charurut Somboonwit, Avindra Nath, John T Sinnott.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21076277      PMCID： PMC4464840          DOI： 10.1097/QAD.0b013e328340fd42

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  198 in total

Review 1.  Translational research models and novel adjunctive therapies for neuroAIDS.

Authors:  M Christine Zink
Journal:  J Neuroimmune Pharmacol       Date:  2007-01-09       Impact factor: 4.147

2.  AIDS vaccine research and advocacy: an update.

Authors:  Emily Bass; Cindra Feuer; Mitchell Warren
Journal:  BETA       Date:  2009 Winter-Spring

3.  Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor.

Authors:  P K Peterson; G Gekker; S Hu; J Lokensgard; P S Portoghese; C C Chao
Journal:  Neuropharmacology       Date:  1999-02       Impact factor: 5.250

4.  The apolipoprotein E epsilon4 allele and memory performance in HIV-1 seropositive subjects: differences at baseline but not after acute oral lorazepam challenge.

Authors:  Nunzio Pomara; Kenneth D Belzer; Raul Silva; Thomas B Cooper; John J Sidtis
Journal:  Psychopharmacology (Berl)       Date:  2008-07-31       Impact factor: 4.530

5.  Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment.

Authors:  Theresa K Smit; Bruce J Brew; Wallace Tourtellotte; Susan Morgello; Benjamin B Gelman; Nitin K Saksena
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections.

Authors:  J M Ward; T J O'Leary; G B Baskin; R Benveniste; C A Harris; P L Nara; R H Rhodes
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

7.  MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells.

Authors:  Mark Eilers; Upal Roy; Debasis Mondal
Journal:  Exp Biol Med (Maywood)       Date:  2008-06-05

8.  Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

Authors:  Scott Letendre; Jennifer Marquie-Beck; Edmund Capparelli; Brookie Best; David Clifford; Ann C Collier; Benjamin B Gelman; Justin C McArthur; J Allen McCutchan; Susan Morgello; David Simpson; Igor Grant; Ronald J Ellis
Journal:  Arch Neurol       Date:  2008-01

Review 9.  The role of host genetics in the susceptibility for HIV-associated neurocognitive disorders.

Authors:  Andrew J Levine; Elyse J Singer; Paul Shapshak
Journal:  AIDS Behav       Date:  2008-02-09

Review 10.  Feline immunodeficiency virus infection: an overview.

Authors:  K Hartmann
Journal:  Vet J       Date:  1998-03       Impact factor: 2.688
View more
  40 in total

1.  Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women.

Authors:  Yamil Gerena; Richard L Skolasky; Joyce M Velez; Dianedis Toro-Nieves; Raul Mayo; Avindra Nath; Valerie Wojna
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

2.  Longitudinal study of emerging mental health concerns in youth perinatally infected with HIV and peer comparisons.

Authors:  Kenneth D Gadow; Konstantia Angelidou; Miriam Chernoff; Paige L Williams; Jerry Heston; Janice Hodge; Sharon Nachman
Journal:  J Dev Behav Pediatr       Date:  2012-07       Impact factor: 2.225

3.  Chronic SIV and morphine treatment increases heat shock protein 5 expression at the synapse.

Authors:  Gurudutt Pendyala; Palsamy Periyasamy; Shannon Callen; Howard S Fox; Steven J Lisco; Shilpa J Buch
Journal:  J Neurovirol       Date:  2015-06-03       Impact factor: 2.643

Review 4.  Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders.

Authors:  Dionna W Williams; Mike Veenstra; Peter J Gaskill; Susan Morgello; Tina M Calderon; Joan W Berman
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

5.  Factors related to HIV-associated neurocognitive impairment differ with age.

Authors:  Gary B Fogel; Susanna L Lamers; Andrew J Levine; Miguel Valdes-Sueiras; Michael S McGrath; Paul Shapshak; Elyse J Singer
Journal:  J Neurovirol       Date:  2014-11-18       Impact factor: 2.643

6.  Expression of mannose binding lectin in HIV-1-infected brain: implications for HIV-related neuronal damage and neuroAIDS.

Authors:  Kumud K Singh; Satyanarayana Nathamu; Anthony Adame; Tara U Alire; Wilmar Dumaop; Ben Gouaux; David J Moore; Eliezer Masliah
Journal:  Neurobehav HIV Med       Date:  2011-05-01

7.  HIV clades B and C are associated with reduced brain volumetrics.

Authors:  Mario Ortega; Jodi M Heaps; John Joska; Florin Vaida; Soraya Seedat; Dan J Stein; Robert Paul; Beau M Ances
Journal:  J Neurovirol       Date:  2013-10       Impact factor: 2.643

Review 8.  Nano-ART and NeuroAIDS.

Authors:  Malay K Das; Anupam Sarma; Tapash Chakraborty
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

9.  A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity versus Functional Activities.

Authors:  Yunyun Yuan; Christopher K Arnatt; Nazira El-Hage; Seth M Dever; Joanna C Jacob; Dana E Selley; Kurt F Hauser; Yan Zhang
Journal:  Medchemcomm       Date:  2013-05-01       Impact factor: 3.597

Review 10.  Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.

Authors:  Kurt F Hauser; Pamela E Knapp
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.